Pernix Therapeutics Holdings, Inc.
PTX
PTX was delisted on the 4th of March, 2019.
114 hedge funds and large institutions have $209M invested in Pernix Therapeutics Holdings, Inc. in 2015 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 55 increasing their positions, 22 reducing their positions, and 28 closing their positions.
150% more repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 22
7% less first-time investments, than exits
New positions opened: 26 | Existing positions closed: 28
3% less funds holding
Funds holding: 117 → 114 (-3)
46% less capital invested
Capital invested by funds: $387M → $209M (-$179M)
75% less funds holding in top 10
Funds holding in top 10: 4 → 1 (-3)
84% less call options, than puts
Call options by funds: $111K | Put options by funds: $699K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Broadfin Capital
New York
|
+$20.5M |
| 2 |
DCM
DG Capital Management
New York
|
+$4.84M |
| 3 |
ECP
Elk Creek Partners
Denver,
Colorado
|
+$4.64M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$3.7M |
| 5 |
JAM
Jupiter Asset Management
London,
United Kingdom
|
+$3.35M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Consonance Capital Management
New York
|
-$34.9M |
| 2 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
-$10.3M |
| 3 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$6.15M |
| 4 |
CM
Castleark Management
Chicago,
Illinois
|
-$5.51M |
| 5 |
CPIM
Columbia Partners Investment Management
Alexandria,
Virginia
|
-$4.7M |
PTX Hedge Fund Activity: Q2 2015 in Review
114 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Pernix Therapeutics Holdings, Inc. (PTX) for Q2 2015, worth a combined $209M — down 46% from $387M a quarter earlier.
Sellers outnumbered buyers: 28 funds closed out of PTX and 26 opened new positions — a net loss of 2 holders — while 22 trimmed existing stakes and 55 added.
The largest buyer was Broadfin Capital, adding an estimated $20.5M. The largest seller was Consonance Capital Management, exiting entirely with an estimated $34.9M sold.
- 114 institutional investors held Pernix Therapeutics Holdings, Inc. (PTX) as of Q2 2015, down from 117 in Q1 2015.
- Funds reported $209M of Pernix Therapeutics Holdings, Inc. stock for Q2 2015, down 46% quarter-over-quarter.
- 26 funds opened new Pernix Therapeutics Holdings, Inc. positions in Q2 2015 and 28 closed out, a net change of -2 holders.
- The largest Pernix Therapeutics Holdings, Inc. buyer in Q2 2015 was Broadfin Capital, an estimated $20.5M added.
- The largest Pernix Therapeutics Holdings, Inc. seller in Q2 2015 was Consonance Capital Management, an estimated $34.9M sold.
Based on aggregated 13F filings for Q2 2015.